Medicine and Dentistry
Interstitial Lung Disease
100%
Idiopathic Pulmonary Fibrosis
86%
Diagnosis
73%
Lung Cancer
71%
Disease
67%
Symptom
42%
Chronic Obstructive Pulmonary Disease
38%
Silo-Filler's Disease
27%
Acoustic Rhinometry
26%
Lung Biopsy
25%
Cohort Analysis
24%
Computer Assisted Tomography
24%
Dyspnea
24%
Asthma
21%
Randomized Controlled Trial
19%
COVID-19
18%
Severe Asthma
18%
Quality of Life
18%
Nasal Cavity
16%
Symptomatic Treatment
15%
Sarcoidosis
15%
Idiopathic Interstitial Pneumonia
15%
Forced Vital Capacity
15%
Biopsy
15%
Malignant Neoplasm
14%
Non Small Cell Lung Cancer
14%
Lung Nodule
13%
Interstitial Lung Disorder
12%
Pirfenidone
12%
Pulmonary Fibrosis
12%
Rheumatoid Arthritis
12%
Systematic Review
12%
Prevalence
12%
Lung Transplantation
12%
High-Resolution Computed Tomography
12%
Infection
11%
Biological Marker
11%
Patient Referral
10%
Observational Study
10%
Biological Product
10%
Clinician
10%
Pneumothorax
9%
Immunotherapy
9%
Cancer Registry
9%
Usual Interstitial Pneumonia
9%
Diagnostic Accuracy
9%
Drug Therapy
9%
Retrospective Cohort Study
9%
Positron Emission Tomography-Computed Tomography
8%
Disease Course
8%
Atypical Mycobacterium
8%
Fibrosis
8%
Low Drug Dose
8%
Disease Exacerbation
8%
Coughing
7%
Rehabilitation Engineering
7%
Allergen
7%
Hypersensitivity Pneumonitis
7%
Cancer Diagnosis
7%
Mediastinal Lymph Node
7%
Respiratory Failure
7%
Nasal Congestion
7%
Obstructive Sleep Apnea
7%
Lung
6%
Lung Infection
6%
Telerehabilitation
6%
Adverse Event
6%
Placebo
6%
Lung Lavage
6%
Bronchoscopy
6%
Endobronchial Ultrasonography
6%
General Medicine
6%
Lung Function
6%
Pulmonary Hypertension
6%
Exercise
6%
Six Minute Walk Test
6%
Hazard Ratio
6%
Emergency Department
6%
Patient-Reported Outcome
6%
Primary Health Care
6%
Nintedanib
5%
Radiation Therapy
5%
Smoking
5%
General Practitioner
5%
Pathophysiology
5%
Thoracentesis
5%
Odds Ratio
5%
Echography
5%
Histopathology
5%
Volume CT
5%
Spirometry
5%
Mycobacterium Avium-Intracellulare Infection
5%
Lower Respiratory Tract Infection
5%
Interferon Gamma Release Assay
5%
Advance Care Planning
5%
Cross Sectional Study
5%
Mortality Rate
5%
Hemidiaphragm
5%
Lymph Node
5%
Diseases
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosing Alveolitis
53%
Lung Cancer
51%
Chronic Obstructive Lung Disease
47%
Interstitial Lung Disease
45%
Disease
35%
Asthma
35%
Cohort Study
24%
Symptom
22%
Randomized Controlled Trial
18%
Lung Disease
16%
Nintedanib
15%
Placebo
15%
Comorbidity
15%
Biological Marker
13%
Prevalence
13%
Non Small Cell Lung Cancer
12%
Biological Product
11%
Adverse Event
10%
Neoplasm
10%
Infection
9%
Inflammation
9%
Pirfenidone
9%
Interstitial Pneumonia
8%
Malignant Neoplasm
8%
Disease Exacerbation
7%
Dyspnea
7%
Observational Study
6%
Pulmonary Hypertension
6%
Atypical Mycobacterium
6%
Lung Nodule
6%
Lung Fibrosis
6%
Allergen
6%
All Cause Mortality
6%
Lung Infection
6%
Remission
5%
Clinical Trial
5%
Fibrosis
5%
Recurrent Disease
5%
Disease Severity
5%
Coronavirinae
5%
Respiratory Tract Disease
5%
Tuberculosis
5%
Indacaterol
5%
Allergic Pneumonitis
5%
Cystic Fibrosis
5%
Immunology and Microbiology
Allergen
31%
Asthma
27%
Immunotherapy
22%
Mast Cell
21%
Severe Asthma
20%
Immunoglobulin E
17%
Comorbidity
15%
Prevalence
14%
Allergic Pneumonitis
11%
Forced Vital Capacity
10%
Allergic Rhinitis
9%
Basophil Granulocyte
9%
Inflammatory Arthritis
8%
Nontuberculous mycobacteria
8%
Biological Product
8%
Lung Function
7%
Allergen Immunotherapy
7%
Basophil Activation
6%
Inflammatory Bowel Disease
6%
Basophil
6%
Comorbidity
6%
Grass Pollen
5%
Computer Assisted Tomography
5%
Respiratory Tract Allergy
5%
Crohn's Disease
5%
Systemic Scleroderma
5%
Surface Property
5%
Breathing
5%
Blood Plasma
5%
Nintedanib
5%